Figure 2From: Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trialAlfa- feto protein (AFP) tumor marker levels: AFP levels and trends before and after Sutent. Arrow points to initiation of Sutent.Back to article page